COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis (UwmBmmscALS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02881489
Recruitment Status : Unknown
Verified August 2016 by Wojciech Maksymowicz, University of Warmia and Mazury.
Recruitment status was:  Enrolling by invitation
First Posted : August 29, 2016
Last Update Posted : August 29, 2016
Information provided by (Responsible Party):
Wojciech Maksymowicz, University of Warmia and Mazury

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : April 2018
Estimated Study Completion Date : December 2018